Ivabradine

Cardiology

Cardiology · Selective If channel inhibitor (SA node)

Ivabradine

Dose

5 mg BD, adjust after 2 weeks to 7.5 mg BD (target HR 50–60).

Mechanism

Slows SA node without affecting contractility or BP.

Indications

  • HFrEF (EF ≤35) in sinus rhythm HR ≥75 despite maximal β-blocker
  • Chronic stable angina intolerant to β-blocker

Contraindications

  • AF/flutter
  • Sick sinus syndrome
  • HR <70 pre-dose
  • Severe hepatic impairment

Use

Add-on to β-blocker in HF if HR remains ≥75.

Monitoring

HR, ECG (for AF onset).

Side effects

  • Bradycardia
  • Phosphenes (luminous visual disturbance)
  • AF
  • Headache

Related in WardRound

Always confirm dose against your local formulary / BNF before prescribing.

WardRound

WardRound

Clinical Decisions in Seconds